Showing results (271-280 of 538) with videos related to

Sort By:
Pageof 54
Clinical Therapeutics|April 7, 2005
Topiramate monotherapy in epilepsy and migraine preventionStephen D Silberstein, Elinor Ben-Menachem, Richard P Shank, et al.
Headache|March 16, 2007
Hemicrania continua-like headache associated with internal carotid artery dissection may respond to indomethacinAvi Ashkenazi, Muhammad A Abbas, Dinesh K Sharma, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 15, 2022
The Arrival of Anti-CGRP Monoclonal Antibodies in MigraineFred Cohen, Hsiangkuo Yuan, E M G DePoy, et al.
Journal of Occupational and Environmental Medicine|January 16, 2004
Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and modelWilliam C Gerth, Syam Sarma, X Henry Hu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 9, 2017
CGRP Monoclonal Antibodies for Migraine: Rationale and ProgressHsiangkuo Yuan, Clinton G Lauritsen, Eric A Kaiser, et al.
Headache|April 29, 2006
Acute migraine treatment: patterns of use and satisfaction in a clinical populationShahram N Malik, Mary Hopkins, William B Young, et al.
Neurology|February 13, 2002
Migraine and autonomic nervous system function: a population-based, case-control studyAaron Shechter, Walter F Stewart, Stephen D Silberstein, et al.
Cephalalgia : an International Journal of Headache|September 21, 2010
Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2János Tajti, Anikó Kuris, László Vécsei, et al.
British Journal of Pharmacology|October 27, 2004
Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the ratKenneth A Petersen, Steffen Birk, Henri Doods, et al.
Pageof 54